Condition
Obstetrical Brachial Plexus Palsy
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed2
Terminated1
Withdrawn1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05403034Not ApplicableCompletedPrimary
Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy
NCT03198702Phase 3RecruitingPrimary
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
NCT03440658CompletedPrimary
Deficits of Strength of the Rotator Muscles of the Shoulder in Children
NCT01933438Not ApplicableTerminated
Sup-ER Protocol RCT
NCT01663428Not ApplicableWithdrawn
Sup-ER Splint for Children With Birth Related Brachial Plexus Injury
Showing all 5 trials